NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit

LOS ANGELES, June 3, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Inari Medical, Inc. (“Inari” or the “Company”) (NASDAQ: NARI). Class Period: February…

Leave a Reply

Your email address will not be published. Required fields are marked *